Inventor · disambiguated record
Shrenik K. Shah
Also filed as: SHAH SHRENIK · SHAH SHRENIK K
51 granted patents·7 pending applications·1,399 citations·filing 1983–2016
99Inventor score
Top patents by PatentIndex Score
58 records- 0199US5719147AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Feb 17, 1998·193 cites·27 claims
- 0297US6372733B1Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthasesMERCK & CO INC·Filed 2000·Granted Apr 16, 2002·158 cites·12 claims
- 0396US4547371ASubstituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agentsMERCK & CO INC·Filed 1983·Granted Oct 15, 1985·56 cites·7 claims
- 0494US6972295B2Substituted amidesMERCK & CO INC·Filed 2003·Granted Dec 6, 2005·61 cites·20 claims
- 0594US5637699AProcess for preparing morpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Jun 10, 1997·85 cites·2 claims
- 0692US6559174B2N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitorsMERCK & CO INC·Filed 2002·Granted May 6, 2003·33 cites·14 claims
- 0791US6013652ASpiro-substituted azacycles as neurokinin antagonistsMERCK & CO INC·Filed 1997·Granted Jan 11, 2000·68 cites·2 claims
- 0890US6248755B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Jun 19, 2001·52 cites·39 claims
- 0990US4623645ASubstituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1983·Granted Nov 18, 1986·26 cites·10 claims
- 1087US5434158ASpiro-substituted azacycles as neurokinin-3 antagonistsMERCK & CO INC·Filed 1994·Granted Jul 18, 1995·62 cites·4 claims
- 1187US5348953ASubstituted azetidinones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1992·Granted Sep 20, 1994·39 cites·27 claims
- 1286US6235735B1Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2000·Granted May 22, 2001·19 cites·18 claims
- 1384US7423067B2Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonistsMERCK & CO INC·Filed 2003·Granted Sep 9, 2008·21 cites·14 claims
- 1481US7091216B2Substituted furo[2,3-b]pyridine derivativesMERCK & CO INC·Filed 2003·Granted Aug 15, 2006·17 cites·14 claims
- 1581US6358979B1N-cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·12 cites·39 claims
- 1680US5629322ACyclic amidine analogs as inhibitors of nitric oxide synthaseMERCK & CO INC·Filed 1995·Granted May 13, 1997·55 cites·16 claims
- 1780US5607936ASubstituted aryl piperazines as neurokinin antagonistsMERCK & CO INC·Filed 1994·Granted Mar 4, 1997·42 cites·12 claims
- 1880US5229381ASubstituted azetidinones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1991·Granted Jul 20, 1993·57 cites·17 claims
- 1979US6943180B2Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitorsMERCK & CO INC·Filed 2002·Granted Sep 13, 2005·14 cites·28 claims
- 2078US5364848ASubstituted cephalosporin sulfones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1992·Granted Nov 15, 1994·16 cites·12 claims
- 2177US6043358AHexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthasesMERCK & CO INC·Filed 1996·Granted Mar 28, 2000·20 cites·8 claims
- 2277US5869489ATrypthophan ureas as neurokinnin antagonistsMERCK & CO INC·Filed 1997·Granted Feb 9, 1999·22 cites·8 claims
- 2377US5869496ASpiro-substituted azacycles as tachykinin receptor antagonistsMERCK & CO INC·Filed 1994·Granted Feb 9, 1999·37 cites·16 claims
- 2477US5591737ASubstituted azetidinones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1993·Granted Jan 7, 1997·18 cites·31 claims
- 2576US7390835B2Aralkyl amines as cannabinoid receptor modulatorsMERCK & CO INC·Filed 2004·Granted Jun 24, 2008·10 cites·11 claims
- 2676US6855708B2N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitorsMERCK & CO INC·Filed 2002·Granted Feb 15, 2005·7 cites·12 claims
- 2776US4699904ATetrazolyl derivatives of β-lactams useful as elastase inhibitorsMERCK & CO INC·Filed 1985·Granted Oct 13, 1987·12 cites·4 claims
- 2875US7057051B2Substituted imidazoles as cannabinoid receptor modulatorsMERCK & CO INC·Filed 2002·Granted Jun 6, 2006·7 cites·8 claims
- 2975US5972975ASubstituted 2-aminopyridines as inhibitors of nitric oxide synthaseMERCK & CO INC·Filed 1995·Granted Oct 26, 1999·50 cites·4 claims
- 3074US5872116AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Feb 16, 1999·14 cites·21 claims
- 3173US7572785B2Substituted imidazoles as cannabinoid receptor modulatorsMERCK & CO INC·Filed 2005·Granted Aug 11, 2009·1 cites·8 claims
- 3273US4845088ATetrazolyl derivatives of beta-lactams useful as elastase inhibitorsMERCK & CO INC·Filed 1987·Granted Jul 4, 1989·10 cites·8 claims
- 3372US8361994B2Primary amine diazeniumdiolate heterocyclic derivativesMERCK SHARP & DOHME·Filed 2012·Granted Jan 29, 2013·2 cites·32 claims
- 3472US6048859AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1999·Granted Apr 11, 2000·26 cites·23 claims
- 3571US6638930B2Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Oct 28, 2003·1 cites·4 claims
- 3667US5132301ASubstituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agentsMERCK & CO INC·Filed 1990·Granted Jul 21, 1992·8 cites·6 claims
- 3766US7816534B2Substituted amidesMERCK SHARP & DOHME·Filed 2009·Granted Oct 19, 2010·0 cites·13 claims
- 3866US6593346B2N-cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2002·Granted Jul 15, 2003·3 cites·27 claims
- 3965US5908842ASubstituted 2-acylamino-pyridines as inhibitors of nitric oxide synthaseMERCK & CO INC·Filed 1995·Granted Jun 1, 1999·11 cites·6 claims
- 4064US5952321ASubstituted azetidinones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1996·Granted Sep 14, 1999·23 cites·19 claims
- 4163US7550489B2Substituted pyridyoxy amidesMERCK & CO INC·Filed 2008·Granted Jun 23, 2009·0 cites·6 claims
- 4261US8754099B2Oxadiazole beta carboline derivatives as antidiabetic compoundsGUO LIANGQIN·Filed 2011·Granted Jun 17, 2014·1 cites·17 claims
- 4360US5922706AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Jul 13, 1999·6 cites·21 claims
- 4459US5747485ASubstituted azetidiones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1997·Granted May 5, 1998·20 cites·10 claims
- 4555US2005234061A1Substituted amidesHAGMANN WILLIAM K·Filed 2005·Application pending·0 cites
- 4650US10456418B2Preparation of pharmaceutical dosage forms containing iron (III) saltsPATEL MAHENDRA R·Filed 2016·Granted Oct 29, 2019·0 cites·13 claims
- 4750US2004248956A1Substituted imidazoles as cannabinoid receptor modulatorsFiled 2003·Application pending·0 cites
- 4847US2007105914A1Substituted sulfonamidesARMSTRONG HELEN M·Filed 2004·Application pending·0 cites
- 4944US5276139AHaptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinonesMERCK & CO INC·Filed 1991·Granted Jan 4, 1994·2 cites·7 claims
- 5044US2005154202A1Substituted aryl amidesFiled 2003·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →